Dennis L. Smith —President & Chief Executive Officer

Dennis has worked in the pharmaceutical industry since 1973, and most recently served as President and Chief Executive Officer of INO Therapeutics LLC., a specialty pharmaceutical company with strengths in development, marketing, and sales of critical care drugs and drug/device combinations, and focused on making innovative therapies available to healthcare professionals and patients. Prior to INO, Dennis spent 15 years with The DuPont Pharmaceutical Company, where he served as President of U.S. Operations, Executive Vice President of Global Health Systems, Executive Vice President in Europe, and Vice President and General Manager in Canada, among numerous other positions at DuPont Pharmaceuticals and DuPont Merck. Dennis was also employed at Baxter International and Sandoz Pharmaceuticals (now Novartis). He is a graduate of Michigan State University and the Lake Forest Graduate School of Business.

Michael A. Pagnotta—Chief Financial Officer

As Chief Financial Officer, Mike Pagnotta is the principal advisor for all of Solstice's fiscal operations, including financial management and reporting, fiscal control, financial compliance and accounting. He supervises all of the Accounting staff, and has responsibility for IT, and facilities.

Mike is a CPA with over 18 years of public accounting experience. He was a partner in a Northern New Jersey CPA firm prior to entering the pharmaceutical industry in 1993. Mike was also a CFO for a privately-held pharmaceutical company and in 1998, as a result of an acquisition, became the Vice President of Commercial Finance for North American operations at a global biopharmaceutical company. In addition to Finance, he has experience in Commercial Operations, Managed Markets Contract Administration, Distribution and Business Development.

Patrick Murphy, Vice President—Operations

As Vice President of Operations, Patrick Murphy oversees the worldwide supply and quality of Myobloc^®/NeuroBloc^® (Botulinum Toxin Type B) Injectable Solution. Patrick is directly responsible for Quality Assurance/Quality Systems, Quality Control, Manufacturing, Supply Chain, Facilities, and Engineering functions. He is also accountable for the management, safety, and security of the botulinum toxin production facility.

Prior to joining Solstice, Patrick served as Vice President of Chemistry, Manufacturing and Controls (CMC) and Operations at Acologix, Inc. He also held various Manufacturing Operations roles at Abgenix, Inc. and Genentech.

Patrick is a member of the Advisory Board of Diversified Bio-Medics, Inc., and holds a B.S. Degree in Biochemistry from the State University of New York at Binghamton. He works at our South San Francisco, California location.